Expanding Proteomics Market Evosep is targeting the rapidly growing clinical and large-scale proteomics market with innovative solutions designed to significantly enhance throughput and robustness, presenting substantial sales opportunities with labs and institutions seeking scalable, efficient proteomics workflows.

Recent Product Launches The launch of Evosep Eno and the introduction of IQ/OQ protocols for the Eno system highlight ongoing developments in high-throughput chromatography platforms, offering potential for sales in research and clinical labs looking to upgrade or expand their proteomics capabilities.

Strategic Industry Engagement Participation in key industry events such as HUPO, ASMS, and WCBP demonstrates Evosep’s active presence in the scientific community, creating opportunities to showcase new solutions to decision-makers within cutting-edge proteomics research and clinical settings.

Key Collaborations Partnership with Thermo Fisher Scientific positions Evosep as a strategic player in the mass spectrometry ecosystem, opening doors for joint sales initiatives and integrated workflows targeting labs that rely on combined sample prep and analytical solutions.

Funding and Market Position With substantial funding of $40M and revenues up to $10M, Evosep is financially positioned to accelerate sales efforts, expand product offerings, and secure new clients in pharmaceutical, academic, and clinical sectors focused on proteomics innovations.